KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $81,942 | -18.9% | 7,745 | +23.0% | 0.00% | – |
| Q1 2022 | $101,000 | +65.6% | 6,296 | +93.0% | 0.00% | – |
| Q3 2021 | $61,000 | +8.9% | 3,263 | +21.9% | 0.00% | – |
| Q2 2021 | $56,000 | -26.3% | 2,676 | 0.0% | 0.00% | – |
| Q1 2021 | $76,000 | -78.6% | 2,676 | -75.3% | 0.00% | -100.0% |
| Q4 2020 | $355,000 | +1167.9% | 10,855 | +1069.7% | 0.00% | – |
| Q3 2020 | $28,000 | -44.0% | 928 | -70.0% | 0.00% | – |
| Q2 2020 | $50,000 | +177.8% | 3,091 | +72.2% | 0.00% | – |
| Q1 2020 | $18,000 | -48.6% | 1,795 | -29.7% | 0.00% | – |
| Q4 2019 | $35,000 | +218.2% | 2,552 | +235.3% | 0.00% | – |
| Q4 2018 | $11,000 | -15.4% | 761 | +0.5% | 0.00% | – |
| Q3 2018 | $13,000 | +18.2% | 757 | +24.7% | 0.00% | – |
| Q2 2018 | $11,000 | +10.0% | 607 | +9.8% | 0.00% | – |
| Q1 2018 | $10,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |